OTCMKTS:CNVVY ConvaTec Group (CNVVY) Stock Price, News & Analysis → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free CNVVY Stock Alerts $13.11 -0.29 (-2.16%) (As of 05/20/2024 ET) Add Compare Share Share Today's Range$13.10▼$13.1150-Day Range$12.17▼$15.0952-Week Range$9.90▼$15.40Volume1,025 shsAverage Volume8,269 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendFinancialsHeadlinesShort Interest Get ConvaTec Group alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode May 20th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 About ConvaTec Group Stock (OTCMKTS:CNVVY)ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.Read More CNVVY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CNVVY Stock News HeadlinesApril 24, 2024 | msn.comConvaTec Group PLC goes ex dividend tomorrowApril 24, 2024 | finance.yahoo.comConvaTec Group PLC's Dividend AnalysisApril 15, 2024 | finance.yahoo.comConvatec launches new Esteem Body™ with Leak Defense™March 19, 2024 | finance.yahoo.comConvaTec Group PLC: Convatec Earnings: Investments in Innovation and Commercial Organization Set Up Strong 2024March 13, 2024 | seekingalpha.comCooper Companies upgraded at J.P. Morgan on outlookMarch 7, 2024 | msn.comConvaTec Group PLC GAAP EPS of $0.06, revenue of $2.14B misses by $130MJanuary 31, 2024 | msn.comAlign Tech stock rallies on Q4 earnings report, 2024 outlookJanuary 26, 2024 | msn.comBausch + Lomb draws double downgrade at J.P. Morgan on spinoff concernsDecember 11, 2023 | finance.yahoo.comConvaTec Group PLC: Convatec Earnings: Solid Revenue Growth Reflects Improved OperationsNovember 1, 2023 | msn.comConvaTec Group Plc - ADR (CNVVY) Price Target Increased by 11.65% to 14.42October 30, 2023 | nypost.comNavy deploys warships to Mediterranean Sea near Israel following Hamas attackSeptember 8, 2023 | marketwatch.comConvaTec Group Says Sten Scheibye to Step Down From BoardAugust 16, 2023 | msn.comConvaTec Group goes ex-dividend tomorrowAugust 3, 2023 | marketwatch.comConvaTec Group PLC 1H Rev $1.06BJuly 22, 2023 | finance.yahoo.comConvaTec Group PLC: Convatec Makes Small Steps Toward Progress on Its TurnaroundJuly 6, 2023 | finance.yahoo.comConvaTec Group PLC: Convatec: Steady Improvements in Innovation and Execution Should Add Up to Improved ReturnsMay 18, 2023 | marketwatch.comConvaTec Raises 2023 Sales ViewMay 2, 2023 | finance.yahoo.comConvaTec Group PLC (LON:CTEC) Stock's On A Decline: Are Poor Fundamentals The Cause?May 1, 2023 | finance.yahoo.comConvaTec Group PLC: ConvaTec Pushes Forward With Turnaround PlanMarch 9, 2023 | finance.yahoo.comConvaTec Group Plc: ConvaTec Delivered More Turnaround Progress in 2022; No Change to Our Fair Value EstimateMarch 9, 2023 | marketwatch.comConvaTec Group PLC FY Rev $2.07BMarch 8, 2023 | marketwatch.comConvaTec Group's 2022 Profit Set to Slip Despite Revenue Rise -- Earnings PreviewJanuary 12, 2023 | ca.finance.yahoo.comConvaTec Group Plc (CNVVF)September 29, 2022 | finance.yahoo.comConvaTec Group Plc: We're Reducing ConvaTec's Uncertainty Rating, but Our Fair Value Estimate Is UnchangedAugust 23, 2022 | finance.yahoo.comConvaTec Group (LON:CTEC) Has More To Do To Multiply In Value Going ForwardSee More Headlines Receive CNVVY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 6/7 Dividend4/25/2024Today5/21/2024Dividend Payable6/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:CNVVY CUSIPN/A CIK1694271 Webwww.convatecgroup.com Phone441189528100FaxN/AEmployees10,136Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Karim Bitar (Age 59)CEO & Director Comp: $3.69MMr. Jonathan Peter Mason (Age 60)Group CFO & Director Comp: $1.97MMr. John HallerExecutive VP and Chief Quality & Operations OfficerDr. Divakar Ramakrishnan Ph.D.Executive VP, Chief Technology Officer and Head of Research & DevelopmentMs. Kate PostansVice President of Investor Relations & Corporate CommunicationsMs. Evelyn Douglas J.D.Executive VP, Chief of Corporate Strategy & Business Development and General CounselMs. Moyra WithycombeInterim Chief People OfficerMs. Kjersti Grimsrud Biotechnology (Age 63)M.Sc., President & COO of Infusion Care Mr. David ShepherdPresident & COO of Global Advanced Wound CareMr. Seth R. Segel (Age 55)President and COO of Continence Care & Home Services Group More ExecutivesKey CompetitorsAddLife AB (publ)OTCMKTS:ADDLFAnsellOTCMKTS:ANSLYAnsellOTCMKTS:ANSLFAsahi InteccOTC:AHICFBATM Advanced CommunicationsOTCMKTS:BTAVFView All Competitors CNVVY Stock Analysis - Frequently Asked Questions Should I buy or sell ConvaTec Group stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CNVVY shares. View CNVVY analyst ratings or view top-rated stocks. How have CNVVY shares performed in 2024? ConvaTec Group's stock was trading at $12.56 at the start of the year. Since then, CNVVY shares have increased by 4.3% and is now trading at $13.1050. View the best growth stocks for 2024 here. Are investors shorting ConvaTec Group? ConvaTec Group saw a decrease in short interest in April. As of April 15th, there was short interest totaling 300 shares, a decrease of 40.0% from the March 31st total of 500 shares. Based on an average trading volume of 4,200 shares, the days-to-cover ratio is presently 0.1 days. View ConvaTec Group's Short Interest. How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group? ConvaTec Group declared a dividend on Tuesday, March 26th. Shareholders of record on Friday, April 26th will be given a dividend of $0.1432 per share on Friday, June 7th. The ex-dividend date is Thursday, April 25th. This is an increase from the stock's previous dividend of $0.06. Read our dividend analysis for CNVVY. Is ConvaTec Group a good dividend stock? ConvaTec Group (OTCMKTS:CNVVY) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.00%. Read our dividend analysis for CNVVY. How do I buy shares of ConvaTec Group? Shares of CNVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CNVVY) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss Ratings4 Cryptos BETTER than BitcoinTrue Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ConvaTec Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.